type full_text History And Physical Findings [REDACTED_PASSPORT] 82 y Female Chinese ADL I, Ambulate with Umbrella Lives with son Houswife, Malaysian Non Smoker Non Drinker NKDA .Â Past Medical History 1. Right Corona Radiata Infarct (Sep 13 and Sept 2019) 2. HTN / HLD 3. AF on apixaban CHADsVAS 6 . Chronic Meds apixaban 2.5 bdÂ Â Â Â Â lisinopril 5 omÂ Â Â Â Â bisoprolol 2.5 omÂ Â Â Â Â atorvastatin 40 om ganfort eye drop BE OM . F/u Thoracics for newly diagnosed lung adenoCa . 22/7/2021 CT: solid nodule in the lingular segment is larger measuring 1.5 x 1.0 x 1.2 cm (se:403/28 se: 406/23 ) compared to 1.4 x 0.8 x 0.8 cm previously (se:403/27 se: 406/23). No other discrete pulmonary nodule is detected. . S/p TBLB 13/8, histo adenoCa . Planned for Uniportal thoracoscopic surgery or open thoracotomy, left upper lobe lingulectomy or lobectomy, mediastinal nodal dissection . Pre op Inx MPI normal ECG AF US carotid: Â Calcified plaque causing less than 50 stenosis in the right carotid bifurcation. Â Heterogeneoues plaque causing less than 50 stenosis in the left carotid bifurcation. Â Patent bilateral internal carotid arteries with no evidence of hemodynamically significant stenosis. Â Less than 50 stenosis in the origin of the right external carotid artery. Â Increased right common carotid artery intima media thickness. Â Antegrade flow in bilateral vertebral arteries. MRI brain: Â Several scattered small foci showing low GRE signal seen in brainstem and left thalamus consistent with prior microbleeds. Â Old infarct noted right corona radiate. No Mets . PET scan: 1)Â Â Mildly FDG avid pulmonary nodularity seen in the lingular region, compatible with known adenocarcinioma. No definitive evidence of mediastinal or hilar adenopathy, 2)Â Â FDG avid hypodensity seen in the thyroid isthmus and left thyroid lobe ultrasonography/FNA is suggested.3)Â Â Mildly bulky in appearance left adrenal gland with mild FDG avidity, still appears physiological in nature, however follow up is suggested.Â 4)Â Â No other FDG avid lesion seen in rest of the imaged body. . PFT: FEV 1 85 , dlco 78 TTE: EF 55 Dilated atria. Left ventricular hypertrophy concentric. Normal left ventricular ejection fraction. Increased left ventricular filling ressure. Aortic annular calcification. Aortic valve sclerosis. Mitral valve thickening. Mitral valve regurgitation mild to moderate. Tricuspid valve regurgitation mild. Normal pulmonary artery systolic pressure . Issues: 1.Â Left UVATS lingulectomy, mediastinal lymph node dissection 07/10/21 Intraop findings: Small chest cavity, bulky lung Generally oozy Tumor at linglar grosslyÂ invading pleura Normal anatomy of lingular PA, vein and bronchus OtherÂ parts of lung, Parietal pleural diaphgragm normal Mildly enlarged AP window,Â hilar, interlobar, inf pul ligament LN removed for histology . Chest tube removed on 10/10/21 Patient tolerated well Nil discomfort post procedure . Histology: (A F) Lung, left lingular segment and mediastinal lymph nodes segmentectomy and lymph node dissection:Pulmonary adenocarcinoma, mixed pattern, 2.2 cm in size. tumour invades visceral pleura. parenchymal resection margin involved by tumour. nine lymph nodes, all negative for metastatic carcinoma (0/9). . Sent for ALK, PDL 1 (histology), eGFR, ROS 1 (DMOC)For lung tumor board 18/10/21, for discussion for ?RT in view of involved margins 2. Acute left MCA stroke Developed aphasia and right UL weakness, with GCS drop on 09/10/21 mRS 0 Deficits: GCS drop, aphasia, right UL weaknessÂ Â Â . NIHSS OA: 18 CT Brain: no ICH. ASPECTS: 5 6. CT A: left M 1 occlusion Mechanism: likely cardioembolic No rtPA ivo recent surgery Underwent EVT on 9/10/21: Angiograms confirmed presence of a left M 1 occlusion.ACE 68 assembled and catheter tip brought to clot face.Single pass TICI 3 recannalisation. Post EVT, kept intubated due to fluctuating GCS Extubated well 10/10/21 Restarted apixaban on 11/10/21 Transferred to GW on 12/10/21 Tolerated PT well, cleared for home with CGT on 14/10/21 Keen for home . Discharged stable and well on 14/10/21 . Plan: Finish course of oral augmentinTCU Prof [REDACTED] [REDACTED] [REDACTED][REDACTED] private clinic, CXR and bloods OAFor Lung TB 18/10/21 Trace histo and DMOC resultsTCU Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] time,FBC/RP LPM and HbA1c Outcome Followup Plan Finish course of oral augmentinTCU Prof [REDACTED] [REDACTED] [REDACTED][REDACTED] private clinic, CXR and bloods OAFor Lung TB 18/10/21 Trace histo and DMOC resultsTCU Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] time,FBC/RP LPM and HbA1c OA